74 related articles for article (PubMed ID: 8179244)
1. [Interferons. Interferons alpha and gamma: indications in systemic diseases].
Blétry O; Papo T
Ann Med Interne (Paris); 1993; 144(8):557-62. PubMed ID: 8179244
[TBL] [Abstract][Full Text] [Related]
2. [Interferon therapy in hematologic neoplasms].
Schwarzinger I; Bettelheim P; Lechner K
Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective multicenter study of the efficacy of interferon alpha in chronic hepatitis C].
Salmerón J; Martín-Vivaldi R; Palacios A; Nogueras F; Aguilar J; de la Mata M; Andrade R; Puertas M; Sánchez H; Santalla F; Bellot V; Quintero D; Díaz F; Pérez Durán MA; Romero M; Luna JD; Ruiz-Extremera A
Med Clin (Barc); 1996 Nov; 107(18):689-92. PubMed ID: 9082077
[TBL] [Abstract][Full Text] [Related]
4. [Interferon-alfa in the treatment of myeloproliferative diseases].
Adam Z
Vnitr Lek; 1993 Dec; 39(12):1210-8. PubMed ID: 8310673
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
[TBL] [Abstract][Full Text] [Related]
8. Analysis of INF-gamma, TNF-alpha and dendritic cells to predict hepatitis C virus recurrence in liver transplant patients.
Ocaña L; Cos J; Quer J; Bilbao I; Palou E; Parra R; Sauleda S; Esteban JI; Guàrdia J; Massuet LI; Margarit C
Transplant Proc; 2005 Nov; 37(9):3951-6. PubMed ID: 16386594
[TBL] [Abstract][Full Text] [Related]
9. [Observation on the effect of GM-CSF and alpha-INF joint treatment on chronic hepatitis B].
Shao C; Liu W; Chen X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):86-9. PubMed ID: 12526313
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous administration of interferon alpha and gamma in patients with metastatic renal cell carcinoma.
Koga S; Nishikido M; Matsuya F; Kanetake H; Saito Y
Anticancer Res; 1999; 19(6C):5547-50. PubMed ID: 10697614
[TBL] [Abstract][Full Text] [Related]
11. [Acute renal insufficiency in renal transplants treated with interferon-alpha for chronic hepatitis C].
Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Tkaczuk J; Durand D; Suc JM
Nephrologie; 1996; 17(4):247-54. PubMed ID: 8768457
[TBL] [Abstract][Full Text] [Related]
12. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
13. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
14. [Alpha interferons--new therapeutic modalities].
Bajcetić M; Zigon N; Samardzić R; Beleslin DB
Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
Wilson LE; Widman D; Dikman SH; Gorevic PD
Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases].
Coutant G; Blétry O; Prin L; Hauteville D; de Puyfontaine O; Abgrall JF; Godeau P
Ann Med Interne (Paris); 1993; 144(4):243-50. PubMed ID: 8368716
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of side effects of interferon-alpha in 72 patients treated for chronic active hepatitis C].
Duché A; Decocq G; Capron-Chivrac D; Andréjak M
Therapie; 1995; 50(5):419-23. PubMed ID: 8571279
[TBL] [Abstract][Full Text] [Related]
18. Interferon alpha in the treatment of chronic myelogenous leukemia.
Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):347-53. PubMed ID: 9883313
[TBL] [Abstract][Full Text] [Related]
19. [Cytokine spectrum in patients with chronic hepatitis C in the treatment with interferon-alpha drugs].
Sobchak DM; Korochkina OV; Monakova EA
Ter Arkh; 2005; 77(2):70-2. PubMed ID: 15807457
[TBL] [Abstract][Full Text] [Related]
20. Use of interferons in atopic (IgE-mediated) diseases.
Pung YH; Vetro SW; Bellanti JA
Ann Allergy; 1993 Sep; 71(3):234-8. PubMed ID: 8372996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
